Anne‐Sophie Garnier

461 total citations
21 papers, 295 citations indexed

About

Anne‐Sophie Garnier is a scholar working on Nephrology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne‐Sophie Garnier has authored 21 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Immunology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne‐Sophie Garnier's work include Renal Diseases and Glomerulopathies (6 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Drug-Induced Adverse Reactions (3 papers). Anne‐Sophie Garnier is often cited by papers focused on Renal Diseases and Glomerulopathies (6 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Drug-Induced Adverse Reactions (3 papers). Anne‐Sophie Garnier collaborates with scholars based in France and Belgium. Anne‐Sophie Garnier's co-authors include Marie Briet, Jean‐François Augusto, Jean‐François Subra, Benoît Brilland, Alain Chevailler, Agnès Duveau, Pascale Jeannin, Johnny Sayegh, Nicolás Henry and Anne Croué and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Nutrients.

In The Last Decade

Anne‐Sophie Garnier

20 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Sophie Garnier France 10 92 91 59 51 34 21 295
Hakkı Arikan Türkiye 12 50 0.5× 153 1.7× 35 0.6× 39 0.8× 17 0.5× 59 410
Yosu Luque France 10 60 0.7× 161 1.8× 60 1.0× 66 1.3× 18 0.5× 44 384
Nicholas Larkins Australia 11 46 0.5× 138 1.5× 22 0.4× 18 0.4× 29 0.9× 46 373
Chia-shi Wang United States 10 56 0.6× 162 1.8× 22 0.4× 16 0.3× 40 1.2× 18 262
Rajan Kapoor United States 8 64 0.7× 43 0.5× 50 0.8× 36 0.7× 9 0.3× 27 294
H. Kâaroud Tunisia 10 78 0.8× 84 0.9× 16 0.3× 34 0.7× 12 0.4× 69 296
David Massicotte‐Azarniouch Canada 10 44 0.5× 41 0.5× 21 0.4× 21 0.4× 12 0.4× 33 221
Naveed Masani United States 8 213 2.3× 181 2.0× 38 0.6× 23 0.5× 20 0.6× 15 315
David Metz United States 11 30 0.3× 88 1.0× 43 0.7× 25 0.5× 9 0.3× 19 360
Abubakr Imam United States 11 70 0.8× 149 1.6× 32 0.5× 10 0.2× 24 0.7× 25 331

Countries citing papers authored by Anne‐Sophie Garnier

Since Specialization
Citations

This map shows the geographic impact of Anne‐Sophie Garnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Sophie Garnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Sophie Garnier more than expected).

Fields of papers citing papers by Anne‐Sophie Garnier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Sophie Garnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Sophie Garnier. The network helps show where Anne‐Sophie Garnier may publish in the future.

Co-authorship network of co-authors of Anne‐Sophie Garnier

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Sophie Garnier. A scholar is included among the top collaborators of Anne‐Sophie Garnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Sophie Garnier. Anne‐Sophie Garnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garnier, Anne‐Sophie, et al.. (2023). Drug-induced glomerular diseases. Therapies. 79(2). 271–281. 6 indexed citations
2.
3.
Garnier, Anne‐Sophie, et al.. (2023). Nephrotoxicity of Amoxicillin and Third-Generation Cephalosporins: An Updated Review. Drug Safety. 46(8). 715–724. 6 indexed citations
4.
Garnier, Anne‐Sophie, et al.. (2021). Drug-Induced Acute Kidney Injury: A Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method. Journal of Clinical Medicine. 10(2). 168–168. 20 indexed citations
5.
Henry, Nicolás, Nicolas Fage, François Beloncle, et al.. (2021). Retrospective and Systematic Analysis of Causes and Outcomes of Thrombotic Microangiopathies in Routine Clinical Practice: An 11-Year Study. Frontiers in Medicine. 8. 566678–566678. 13 indexed citations
6.
Garnier, Anne‐Sophie, et al.. (2021). Impact of the COVID-19 Pandemic on Training and Well-Being of Nephrology Residents in France and Belgium. Kidney International Reports. 7(3). 653–655. 1 indexed citations
7.
Foudi, Nabil, et al.. (2021). Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches. Journal of Clinical Medicine. 10(17). 3803–3803. 5 indexed citations
8.
Henry, Nicolás, Massimo Torreggiani, Anne‐Sophie Garnier, et al.. (2021). Humoral response to a third injection of BNT162b2 vaccine in patients on maintenance haemodialysis. Clinical Kidney Journal. 14(11). 2349–2355. 41 indexed citations
9.
Brilland, Benoît, Julien Demiselle, Agnès Duveau, et al.. (2020). Renal biopsy in very elderly patients (over 80 years): clinical presentation, histological diagnosis, and long-term outcome. International Urology and Nephrology. 52(4). 721–729. 1 indexed citations
10.
Garnier, Anne‐Sophie, Benoît Brilland, Laurence Lagarce, et al.. (2020). High Incidence of Amoxicillin-Induced Crystal Nephropathy in Patients Receiving High Dose of Intravenous Amoxicillin. Journal of Clinical Medicine. 9(7). 2022–2022. 17 indexed citations
11.
Brilland, Benoît, Anne‐Sophie Garnier, Alain Chevailler, et al.. (2019). Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside. Autoimmunity Reviews. 19(1). 102424–102424. 54 indexed citations
12.
Garnier, Anne‐Sophie, Anne Croué, Alain Chevailler, et al.. (2019). Clinico-pathological considerations in a 48-years-old female with acute kidney injury: is it lupus nephritis, ANCA-associated vasculitis or something else?. BMC Nephrology. 20(1). 334–334. 2 indexed citations
13.
Garnier, Anne‐Sophie, Giorgina Barbara Piccoli, Assia Djema, et al.. (2019). Patients with ANCA-Associated Glomerulonephritis and Connective Tissue Diseases: A Comparative Study from the Maine-Anjou AAV Registry. Journal of Clinical Medicine. 8(8). 1218–1218. 11 indexed citations
14.
Bataille, Stanislas, et al.. (2019). Domicile : où sont les freins ? enquête auprès des néphrologues Français. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Garnier, Anne‐Sophie, Jérémie Riou, C. Jacquemin, et al.. (2019). Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation. PLoS ONE. 14(3). e0214321–e0214321. 5 indexed citations
16.
Garnier, Anne‐Sophie, Agnès Duveau, Julien Demiselle, et al.. (2018). Early post-transplant serum IgA level is associated with IgA nephropathy recurrence after kidney transplantation. PLoS ONE. 13(4). e0196101–e0196101. 13 indexed citations
17.
Garnier, Anne‐Sophie, et al.. (2018). Serum Magnesium after Kidney Transplantation: A Systematic Review. Nutrients. 10(6). 729–729. 27 indexed citations
18.
Garnier, Anne‐Sophie, Caroline Poli, Jean‐François Subra, et al.. (2018). Anticorps anti-pentraxine au cours des maladies auto-immunes. Revue Francophone des Laboratoires. 2018(499). 38–46.
19.
Augusto, Jean‐François, Anne‐Sophie Garnier, Julien Demiselle, et al.. (2016). Hypogammaglobulinemia and risk of severe infection in kidney transplant recipients. Transplant Infectious Disease. 18(5). 741–751. 20 indexed citations
20.
Garnier, Anne‐Sophie & Marie Briet. (2015). Arterial Stiffness and Chronic Kidney Disease. PubMed. 3(3-4). 229–241. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hakkı Arikan Breakdown of academic impact, for papers by Yosu Luque Breakdown of academic impact, for papers by Nicholas Larkins Breakdown of academic impact, for papers by Chia-shi Wang Breakdown of academic impact, for papers by Rajan Kapoor Breakdown of academic impact, for papers by H. Kâaroud Breakdown of academic impact, for papers by David Massicotte‐Azarniouch Breakdown of academic impact, for papers by Naveed Masani Breakdown of academic impact, for papers by David Metz Breakdown of academic impact, for papers by Abubakr Imam
Rankless by CCL
2026